Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:387573rdf:typepubmed:Citationlld:pubmed
pubmed-article:387573lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C0024143lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1561577lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1514811lld:lifeskim
pubmed-article:387573lifeskim:mentionsumls-concept:C1706462lld:lifeskim
pubmed-article:387573pubmed:issue4lld:pubmed
pubmed-article:387573pubmed:dateCreated1980-1-24lld:pubmed
pubmed-article:387573pubmed:abstractTextSince 1970 in 27 out of 46 patients with the diagnosis of systemic lupus erythematosus (SLE) a renal biopsy could be taken. The morphological outcome was followed in 14 patients with a total of 18 repeated biopsies. By light- and electron microscopy renal involvement was demonstrable in all patients. Four histologic subgroups could be differentiated: Mesangio-proliferative (MESLN, 14), focal proliferative (FLN, 6), diffus proliferative (DLN, 6), and membranous lupus nephritis (MLN, 1). Some biopsies demonstrated linear deposits with IgG/IgA-specificity. 2/27 patients only showed a clinical deteriorating course with progressive renal insufficiency despite steroid or steroid-azathioprine therapy. One patient with DLN died in terminal renal failure. The morphological follow-up showed an unfavourable course in 3/14 patients only. One MESLN demonstrated a transition to DLN, one DLN an increase of proliferative lesions and a second DLN focal and local sclerosis. In our experience renal involvement in SLE can adequately characterised and controlled by repeated be clinico-pathological correlations an aggressive therapeutic regimen is not indicated and can be avoided.lld:pubmed
pubmed-article:387573pubmed:languagegerlld:pubmed
pubmed-article:387573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:387573pubmed:citationSubsetIMlld:pubmed
pubmed-article:387573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:387573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:387573pubmed:statusMEDLINElld:pubmed
pubmed-article:387573pubmed:monthAuglld:pubmed
pubmed-article:387573pubmed:issn0340-1162lld:pubmed
pubmed-article:387573pubmed:authorpubmed-author:AlexanderMMlld:pubmed
pubmed-article:387573pubmed:authorpubmed-author:KampfDDlld:pubmed
pubmed-article:387573pubmed:authorpubmed-author:HöferWWlld:pubmed
pubmed-article:387573pubmed:authorpubmed-author:MisgeldVVlld:pubmed
pubmed-article:387573pubmed:issnTypePrintlld:pubmed
pubmed-article:387573pubmed:volume7lld:pubmed
pubmed-article:387573pubmed:ownerNLMlld:pubmed
pubmed-article:387573pubmed:authorsCompleteYlld:pubmed
pubmed-article:387573pubmed:pagination121-8lld:pubmed
pubmed-article:387573pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-H...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-H...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-K...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-N...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-L...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-S...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-P...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-F...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-M...lld:pubmed
pubmed-article:387573pubmed:meshHeadingpubmed-meshheading:387573-A...lld:pubmed
pubmed-article:387573pubmed:year1979lld:pubmed
pubmed-article:387573pubmed:articleTitle[Clinico-pathological correlations in lupus nephritis with reference to therapeutic and prognostic aspects (author's transl)].lld:pubmed
pubmed-article:387573pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:387573pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:387573pubmed:publicationTypeReviewlld:pubmed